Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Oral Apremilast effectively treats alopecia areata in most patients.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Keratin from hair binds well to gold and BMP-2, useful for bone repair.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.